Drugs & Targets FDA grants Orphan Drug Designation to Reolysin in pancreatic cancer February 20, 2015Vol.41 No.07
Drugs & Targets FDA expands indication for Revlimid to include multiple myeloma February 20, 2015Vol.41 No.07
In Brief Multiple Myeloma Research Foundation and Inflection Biosciences announce collaboration February 13, 2015Vol.41 No.06
Drugs & Targets E.U. Expands Velcade Label; ODAC to Examine Talimogene Laherparepvec in Melanoma February 13, 2015Vol.41 No.06
In Brief Wendy Selig to step down as president and CEO of the Melanoma Research Alliance February 13, 2015Vol.41 No.06
In Brief UT Southwestern and a Texas consortium to establish first U.S. heavy ion radiation therapy center February 13, 2015Vol.41 No.06
